Antibody-drug conjugates combined with immunotherapy have redefined the standard of care for advanced bladder cancer, ...

A supplemental Biologics License Application has been submitted to the FDA for Anktiva plus BCG in papillary NMIBC.

The following is a summary of “Comparison of hyperthermic intravesical chemotherapy using pirarubicin and Bacillus ...

During a live event, Matthew Galsky, MD, discussed adjuvant nivolumab in muscle-invasive bladder cancer and the benefit in ...

A supplemental biologics license application has been submitted to the FDA for nogapendekin alfa plus Bacillus ...

The following is a summary of “Cytokeratin 17 activates AKT signaling to induce epithelial-mesenchymal transition and promote bladder cancer progression,” published in the April 2025 issue of BMC ...

New research suggests that an “often-overlooked” parasitic infection, already linked to bladder cancer, may also raise the risk of cervical cancer.

Common childhood infections once considered mere inconveniences may provide unexpected long-term benefits. Emerging research suggests certain illnesses ...

A new systematic review explores how prehabilitation—through exercise, education, nutrition, and lifestyle changes—affects ...

More importantly, even if it’s imperfect it could lead to earlier detection, which remains the single biggest factor in ...

A pattern of Hodgkin's disease in South Patrick Shores first emerged in 1967 near the site of an old naval base ...